YuanC, Li J, Mahajan A,et al.Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship[J]. Biochemistry , 2004, 43(38):12152-12161.
[4]
HigashitsujiH, Itoh K, Nagao T,?et al.?Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas[J]. Nat Med , 2000,6(1):96-99.
[5]
HoriT, Kato S, Saeki M,?et al.?cDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome[J]. Gene , 1998, 216(1):113-122.
[6]
FuXY, Wang HY, Tan L,?et al.?Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance[J]. World J Gastroenterol?,?2002,8(4):638-643.
[7]
Sun W, Ding J, Wu K, et al. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of hepatocytes and hepatoma cells[J].Hepatology, 2011.
[8]
DesplancqD, Rinaldi AS, Horzer H,?et al.?Automated overexpression and isotopic labelling of biologically active oncoproteins in the cyanobacterium Anabaena sp. PCC 7120[J]. Biotechnol Appl Biochem, 2008, 51(Pt 1):53-61.
[9]
LiH, Fu X, Chen Y,?et al.?Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma[J]. Gastroenterology, 2005,128(7):2029-2041.
